(Q48160047)

English

Trospium chloride has no effect on memory testing and is assay undetectable in the central nervous system of older patients with overactive bladder

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

9 February 2018

http://europepmc.org/abstract/MED/20561092

Trospium chloride has no effect on memory testing and is assay undetectable in the central nervous system of older patients with overactive bladder (English)

1 reference

Europe PubMed Central

PubMed publication ID

9 February 2018

http://europepmc.org/abstract/MED/20561092

author name string

D Staskin

1

1 reference

Europe PubMed Central

PubMed publication ID

9 February 2018

http://europepmc.org/abstract/MED/20561092

G Kay

2

1 reference

Europe PubMed Central

PubMed publication ID

9 February 2018

http://europepmc.org/abstract/MED/20561092

C Tannenbaum

3

1 reference

Europe PubMed Central

PubMed publication ID

9 February 2018

http://europepmc.org/abstract/MED/20561092

H B Goldman

4

1 reference

Europe PubMed Central

PubMed publication ID

9 February 2018

http://europepmc.org/abstract/MED/20561092

K Bhashi

5

1 reference

Europe PubMed Central

PubMed publication ID

9 February 2018

http://europepmc.org/abstract/MED/20561092

J Ling

6

1 reference

Europe PubMed Central

PubMed publication ID

9 February 2018

http://europepmc.org/abstract/MED/20561092

M G Oefelein

7

1 reference

Europe PubMed Central

PubMed publication ID

9 February 2018

http://europepmc.org/abstract/MED/20561092

publication date

17 June 2010

1 reference

Europe PubMed Central

PubMed publication ID

9 February 2018

http://europepmc.org/abstract/MED/20561092

International Journal of Clinical Practice

1 reference

Europe PubMed Central

PubMed publication ID

9 February 2018

http://europepmc.org/abstract/MED/20561092

64

1 reference

Europe PubMed Central

PubMed publication ID

9 February 2018

http://europepmc.org/abstract/MED/20561092

9

1 reference

Europe PubMed Central

PubMed publication ID

9 February 2018

http://europepmc.org/abstract/MED/20561092

1294-1300

1 reference

Europe PubMed Central

PubMed publication ID

9 February 2018

http://europepmc.org/abstract/MED/20561092

The standardisation of terminology of lower urinary tract function: report from the Standardisation Sub-committee of the International Continence Society.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-1241.2010.02433.X

21 January 2018

Antimuscarinic drugs for overactive bladder and their potential effects on cognitive function in older patients

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-1241.2010.02433.X

21 January 2018

Central nervous system safety of anticholinergic drugs for the treatment of overactive bladder in the elderly

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-1241.2010.02433.X

21 January 2018

Antimuscarinic agents: implications and concerns in the management of overactive bladder in the elderly

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-1241.2010.02433.X

21 January 2018

Risk of delirium with concomitant use of tolterodine and acetylcholinesterase inhibitors

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-1241.2010.02433.X

21 January 2018

Transient memory impairment and hallucinations associated with tolterodine use.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-1241.2010.02433.X

21 January 2018

Tolterodine and memory: dry but forgetful

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-1241.2010.02433.X

21 January 2018

Assessment of cognitive function of the elderly population: effects of darifenacin

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-1241.2010.02433.X

21 January 2018

Pharmacodynamic effects of darifenacin, a muscarinic M selective receptor antagonist for the treatment of overactive bladder, in healthy volunteers

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-1241.2010.02433.X

21 January 2018

Astrocyte-endothelial interactions at the blood-brain barrier

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-1241.2010.02433.X

21 January 2018

Muscarinic receptor antagonists for overactive bladder

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-1241.2010.02433.X

21 January 2018

Clinical pharmacokinetics of trospium chloride

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-1241.2010.02433.X

21 January 2018

Trospium chloride: A quaternary amine with unique pharmacologic properties

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-1241.2010.02433.X

21 January 2018

Detecting change: A comparison of three neuropsychological methods, using normal and clinical samples

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-1241.2010.02433.X

21 January 2018

“Mini-mental state”

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-1241.2010.02433.X

21 January 2018

Trospium chloride once-daily extended release is effective and well tolerated for the treatment of overactive bladder syndrome: an integrated analysis of two randomised, phase III trials

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-1241.2010.02433.X

21 January 2018

Effects of tolterodine, trospium chloride, and oxybutynin on the central nervous system

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-1241.2010.02433.X

21 January 2018

Effects on sleep of anticholinergics used for overactive bladder treatment in healthy volunteers aged > or = 50 years

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-1241.2010.02433.X

21 January 2018

Randomised, double-blind study of the effects of oxybutynin, tolterodine, trospium chloride and placebo on sleep in healthy young volunteers

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-1241.2010.02433.X

21 January 2018

Oxybutynin and cognitive dysfunction

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-1241.2010.02433.X

21 January 2018

The role of p-glycoprotein in limiting brain penetration of the peripherally acting anticholinergic overactive bladder drug trospium chloride

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-1241.2010.02433.X

21 January 2018

Increased blood-brain barrier permeability in type II diabetes demonstrated by gadolinium magnetic resonance imaging

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-1241.2010.02433.X

21 January 2018

Stress and combined exposure to low doses of pyridostigmine bromide, DEET, and permethrin produce neurochemical and neuropathological alterations in cerebral cortex, hippocampus, and cerebellum

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-1241.2010.02433.X

21 January 2018

The MDR1 (ABCB1) gene polymorphism and its clinical implications

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-1241.2010.02433.X

21 January 2018

Identifiers

10.1111/J.1742-1241.2010.02433.X

1 reference

Europe PubMed Central

PubMed publication ID

9 February 2018

http://europepmc.org/abstract/MED/20561092

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

9 February 2018

http://europepmc.org/abstract/MED/20561092

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q48160047&oldid=2188014843"